fashion -WSS

fashion

author：focus 2025-09-27 22:59:40 - browse：41786

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Grail faces three suits alleging harassment, retaliation

WSS

J&J expands global access to TB drug amid advocacy campaign

Does aspartame cause cancer? What new WHO guidance says

J&J expands global access to TB drug amid advocacy campaign

Grail faces three suits alleging harassment, retaliation

Europe sees delivery challenges ahead on Alzheimer's therapies

Federal judge rules Oregon’s tough new gun law is constitutional

entertainment

fashion

focus

Trump demands the U.S. pay no more for drugs than other countries … again

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

J&J expands global access to TB drug amid advocacy campaign

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Care demand spikes challenge UnitedHealth’s provider arm

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Gene therapy denied for Afghan refugee whose father aided U.S.

Medical records are filled with copy

Arena BioWorks launches in Cambridge to speed drug discovery

leisure time

Gene therapy denied for Afghan refugee whose father aided U.S.

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Physician assistants need a new name. Here's what it should be

Everything to know for the next Powerball drawing as jackpot hits $1 billion

A preacher's new calling: Diversifying neuroscience research

Arena BioWorks launches in Cambridge to speed drug discovery

explore

entertainment

leisure time

hotspot